Answers are grounded in this paper and cite their sources.
Deep learning model improves diagnostic accuracy in prostate cancer, suggesting a valuable tool for clinicians.
Background: Prostate cancer is a prevalent malignancy in males, with prostate MRI imaging as the primary diagnostic method. However, this method is subjective and can miss early-stage cancers, necessitating more efficient diagnostic techniques. Method: In this study, we introduced the PRAD-Hybrid CNN (Prostate Adenocarcinoma Hybrid Convolutional Neural Network, PRADHC) model, a novel amalgamation of EfficientNet and Residual Blocks, which was developed and validated on 1,528 MRI images from 64 patients. By strategically increasing the number of Convolutional Neural Network (CNN) layers in the EfficientNet architecture, our model improved the diagnostic accuracy inherent to the original EfficientNet. Additionally, the integration of Residual Networks (ResNet) successfully mitigated the gradient vanishing issue often encountered during the training of deeper models, thereby significantly enhancing training accuracy. This innovative model, thus, offers clinicians an efficacious tool for assisted diagnosis. Result: The PRADHC model, upon validation, achieved an accuracy of 99.34% and an AUC of 99.32%, a 4% improvement over the conventional EfficientNet. The baseline elementary CNN model achieved 95.72% accuracy and 96.74% AUC, which is still lower than the PRADHC model. Conclusion: This study introduces a novel deep learning model designed specifically for the automated diagnosis of prostate cancer. This model aims to enhance diagnostic accuracy, especially in the early stages of the disease. Such advancements have the potential to augment the diagnostic proficiency of both radiologists and urologists, assisting them in more informed decision-making regarding treatment planning. However, it is imperative to acknowledge that false-positive lesion detections remain a limitation of AI-assisted diagnostic tools. Nevertheless, this system can serve as a valuable supplementary instrument for radiologists in their diagnostic endeavors.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: